Clinical trial
Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma
NCT00927771 is registered in ClinicalTrials.gov with Callender Center for Clinical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma
- Lead sponsor
- Callender Center for Clinical Research
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2009
- Completion date
- December 31, 2010
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.